Peters, A. (2022) “Safety and tolerability of Bruton’s tyrosine kinase inhibitors in the treatment of Waldenström macroglobulinemia”, Canadian Hematology Today. Toronto, Canada, 1(S06). doi: 10.58931/cht.2022.1S0628.